Meeting of the National Advisory Council for Healthcare Research and Quality, 59625 [2019-24081]

Download as PDF Federal Register / Vol. 84, No. 214 / Tuesday, November 5, 2019 / Notices khammond on DSKJM1Z7X2PROD with NOTICES the aggregation and analysis of patient safety events. The Patient Safety Act authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity are to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety Rule to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule relating to the listing and operation of PSOs. The Patient Safety Rule authorizes AHRQ to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of PSOs. AHRQ has accepted a notification of proposed voluntary relinquishment from Symbria SAFE, a component entity of Symbria Inc., to voluntarily relinquish its status as a PSO. Accordingly, Symbria SAFE, P0146, was delisted effective at 12:00 Midnight ET (2400) on October 31, 2019. Symbria SAFE has patient safety work product (PSWP) in its possession. The PSO will meet the requirements of section 3.108(c)(2)(i) of the Patient Safety Rule regarding notification to providers that have reported to the PSO and of section 3.108(c)(2)(ii) regarding disposition of PSWP consistent with section 3.108(b)(3). According to section 3.108(b)(3) of the Patient Safety Rule, the PSO has 90 days from the effective date of delisting and revocation to complete the disposition of PSWP that is currently in the PSO’s possession. More information on PSOs can be obtained through AHRQ’s PSO website at http://www.pso.ahrq.gov. Virginia Mackay-Smith, Associate Director. [FR Doc. 2019–24152 Filed 11–4–19; 8:45 am] BILLING CODE 4160–90–P VerDate Sep<11>2014 16:34 Nov 04, 2019 Jkt 250001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of public meeting. AGENCY: This notice announces a meeting of the National Advisory Council for Healthcare Research and Quality. DATES: The meeting will be held on Thursday, November 21, 2019, from 8:30 a.m. to 12:00 p.m. ADDRESSES: The meeting will be held at AHRQ, 5600 Fishers Lane, Rockville, Maryland, 20857. FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427– 1456. For press-related information, please contact Bruce Seeman at (301) 427–1998 or Bruce.Seeman@ AHRQ.hhs.gov. If sign language interpretation or other reasonable accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827–4840, no later than Thursday, November 7, 2019. The agenda, roster, and minutes will be available from Ms. Heather Phelps, Committee Management Officer, Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland 20857. Ms. Phelps’ phone number is (301) 427–1128. SUPPLEMENTARY INFORMATION: SUMMARY: I. Purpose In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App., this notice announces a meeting of the National Advisory Council for Healthcare Research and Quality (the Council). The Council is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 59625 information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. II. Agenda On Thursday, November 21, 2019, the Council meeting will convene at 8:30 a.m., with the call to order by the Council Chair and approval of previous Council summary notes. The meeting is open to the public and will be available via webcast at www.webconferences.com/ahrq. The meeting will begin with an update on AHRQ’s budget, programs and initiatives. The agenda will also include a discussion about the challenges and opportunities to leverage AHRQ’s CDS Connect to improve care and a conversation about the gaps and opportunities for improving care, with a focus on social determinants of health. The meeting will adjourn at 12:00 p.m. The final agenda will be available on the AHRQ website at www.AHRQ.gov no later than Thursday, November 14, 2019. Dated: October 30, 2019. Virginia L. Mackay-Smith, Associate Director. [FR Doc. 2019–24081 Filed 11–4–19; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Reporting of Pregnancy Success Rates From Assisted Reproductive Technology (ART) Programs; Clarifications and Corrections Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Disease Control and Prevention (CDC), located within the Department of Health and Human Services (HHS), announces clarifications for and correction to certain data collection fields, terminology, and definitions used for reporting of pregnancy success rates from assisted reproductive technology (ART) programs. This reporting is required by the Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA). SUMMARY: E:\FR\FM\05NON1.SGM 05NON1

Agencies

[Federal Register Volume 84, Number 214 (Tuesday, November 5, 2019)]
[Notices]
[Page 59625]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24081]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Meeting of the National Advisory Council for Healthcare Research 
and Quality

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the National Advisory 
Council for Healthcare Research and Quality.

DATES: The meeting will be held on Thursday, November 21, 2019, from 
8:30 a.m. to 12:00 p.m.

ADDRESSES: The meeting will be held at AHRQ, 5600 Fishers Lane, 
Rockville, Maryland, 20857.

FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management 
Official, at the Agency for Healthcare Research and Quality, 5600 
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland 20857, (301) 427-
1456. For press-related information, please contact Bruce Seeman at 
(301) 427-1998 or [email protected].
    If sign language interpretation or other reasonable accommodation 
for a disability is needed, please contact the Food and Drug 
Administration (FDA) Office of Equal Employment Opportunity and 
Diversity Management on (301) 827-4840, no later than Thursday, 
November 7, 2019. The agenda, roster, and minutes will be available 
from Ms. Heather Phelps, Committee Management Officer, Agency for 
Healthcare Research and Quality, 5600 Fishers Lane, Rockville, Maryland 
20857. Ms. Phelps' phone number is (301) 427-1128.

SUPPLEMENTARY INFORMATION:

I. Purpose

    In accordance with section 10(a) of the Federal Advisory Committee 
Act, 5 U.S.C. App., this notice announces a meeting of the National 
Advisory Council for Healthcare Research and Quality (the Council). The 
Council is authorized by Section 941 of the Public Health Service Act, 
42 U.S.C. 299c. In accordance with its statutory mandate, the Council 
is to advise the Secretary of the Department of Health and Human 
Services and the Director of AHRQ on matters related to AHRQ's conduct 
of its mission including providing guidance on (A) priorities for 
health care research, (B) the field of health care research including 
training needs and information dissemination on health care quality and 
(C) the role of the Agency in light of private sector activity and 
opportunities for public private partnerships. The Council is composed 
of members of the public, appointed by the Secretary, and Federal ex-
officio members specified in the authorizing legislation.

II. Agenda

    On Thursday, November 21, 2019, the Council meeting will convene at 
8:30 a.m., with the call to order by the Council Chair and approval of 
previous Council summary notes. The meeting is open to the public and 
will be available via webcast at www.webconferences.com/ahrq. The 
meeting will begin with an update on AHRQ's budget, programs and 
initiatives. The agenda will also include a discussion about the 
challenges and opportunities to leverage AHRQ's CDS Connect to improve 
care and a conversation about the gaps and opportunities for improving 
care, with a focus on social determinants of health. The meeting will 
adjourn at 12:00 p.m. The final agenda will be available on the AHRQ 
website at www.AHRQ.gov no later than Thursday, November 14, 2019.

    Dated: October 30, 2019.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2019-24081 Filed 11-4-19; 8:45 am]
BILLING CODE 4160-90-P